CagriSema combines cagrilintide (an amylin analog) with semaglutide
Because fat often returns after stopping, some patients continue maintenance therapy under supervision
587 When topical treatments are insufficient, Botulinum Toxin Type A injections into the affected areas inhibit acetylcholine release at neuromuscular junctions, resulting in a significant reduction in sweating for several months
Clearly, the growing body of evidence supports GLP-1s actions in skeletal muscle and adipose tissue as important contributors to effective glucose management, although the exact mechanism is not yet known
Nystrom T, Gutniak MK, Zhang Q, Zhang F, Holst JJ, Ahrn B, Sjholm A
each dose splits ~50/50 between the two peptides